Tianyin Pharmaceutical Co Valuation

Tianyin Pharmaceutical Investor Information

About 26.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.05. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tianyin Pharmaceutical recorded a loss per share of 0.14. The entity last dividend was issued on the January 27, 2010. Tianyin Pharmaceutical Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.

Tianyin Pharmaceutical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tianyin Pharmaceutical has an asset utilization ratio of 29.24 percent. This signifies that the Company is making 0.29 for each dollar of assets. An increasing asset utilization means that Tianyin Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.

Tianyin Pharmaceutical Ownership Allocation

Tianyin Pharmaceutical shows a total of 29.43 Million outstanding shares. Tianyin Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Tianyin Pharmaceutical Profitability Analysis

The company reported the last year's revenue of 29.64 M. Reported Net Loss for the year was (4.07 M) with profit before taxes, overhead, and interest of 15.88 M.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.